Further insight into AE37 peptide vaccination in prostate cancer

Future Sci OA. 2017 May 11;3(3):FSO192. doi: 10.4155/fsoa-2017-0005. eCollection 2017 Aug.

Authors

Eleftheria A Anastasopoulou¹, Ioannis F Voutsas¹

Affiliation

¹ Cancer Immunology & Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece.

No abstract available

Keywords: cancer vaccines; clinical trials; immunotherapy; patient selection; pre-existing immunity; prostate cancer.

Publication types

Editorial